Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis

被引:295
作者
Osugi, Y
Hara, J
Tagawa, S
Takai, K
Hosoi, G
Matsuda, Y
Ohta, H
Fujisaki, H
Kobayashi, M
Sakata, N
KawaHa, K
Okada, S
Tawa, A
机构
[1] OSAKA MED CTR,DEPT PEDIAT,OSAKA,JAPAN
[2] RES INST MATERNAL & CHILD HLTH,OSAKA,JAPAN
[3] OSAKA CITY UNIV,SCH MED,DEPT CLIN HEMATOL,OSAKA 545,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
关键词
D O I
10.1182/blood.V89.11.4100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophagocytic lymphohistiocytosis (HLH) is caused by the hyperactivation of T cells and macrophages. The clinical characteristics associated with this disease result from overproduction of Th1 cytokines including interferon-gamma (IFN-gamma), interleukin-2 (IL-2), and tumor necrosis factor-alpha (TNF-alpha). In this study, we analyzed the production of IL-12 and IL-4, which determine Th1 and Th2 response, respectively, and IL-10, which antagonizes Th1 cytokines, in 11 patients with HLH. IL-12 was detected in plasma in all patients (mean peak value, 30.0 +/- 5.0 pg/mL), while IFN-gamma was massively produced in nine patients (mean peak value, 79.2 +/- 112.0 U/mL). IL-4 was not detected in any of the patients. Plasma IL-10 levels were elevated in ail patients (mean peak value, 2,698.0 +/- 3,535.0 pg/mL). There was a positive correlation between the levels of IFN-gamma and IL-10 (P < .01). The plasma concentrations of these cytokines were initially high, before decreasing after the acute phase. However, the decrease in IL-10 levels was slower than that of IFN-gamma. Although the concentration of IL-12 was high at the acute phase, in some patients, a peak in the level was delayed until the chronic phase. Thus, in HLH, production of cytokines that promote development of Th1 cells appears to be predominant over that for Th2 cell development. Overproduction of IL-10 was also observed indicating that a mechanism suppressing hyperactivation of Th1 cells and monocytes/macrophages functions in patients with this disease. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:4100 / 4103
页数:4
相关论文
共 31 条
[1]   INVOLVEMENT OF INTERFERON-GAMMA AND MACROPHAGE-COLONY-STIMULATING FACTOR IN PATHOGENESIS OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS [J].
AKASHI, K ;
HAYASHI, S ;
GONDO, H ;
MIZUNO, S ;
HARADA, M ;
TAMURA, K ;
YAMASAKI, K ;
SHIBUYA, T ;
UIKE, N ;
OKAMURA, T ;
MIYAMOTO, T ;
NIHO, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :243-250
[2]  
CLINE MJ, 1994, BLOOD, V84, P2840
[3]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[4]  
De Vries JE, 1995, INTERLEUKIN 10
[5]   MODULATION OF THE RELEASE OF CYTOKINES AND REDUCTION OF THE SHOCK SYNDROME INDUCED BY ANTI-CD3 MONOCLONAL-ANTIBODY IN MICE BY INTERLEUKIN-10 [J].
DONCKIER, V ;
FLAMENT, V ;
GERARD, C ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
WISSING, M ;
DELVAUX, A ;
FIERS, W ;
LEO, O ;
VELU, T ;
GOLDMAN, M .
TRANSPLANTATION, 1994, 57 (10) :1436-1439
[6]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095
[7]  
FLORQUIN S, 1994, J IMMUNOL, V153, P2618
[8]   HYPERCYTOKINEMIA IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS [J].
HENTER, JI ;
ELINDER, G ;
SODER, O ;
HANSSON, M ;
ANDERSSON, B ;
ANDERSSON, U .
BLOOD, 1991, 78 (11) :2918-2922
[9]   EXPRESSION OF INTERLEUKIN-10 ACTIVITY BY EPSTEIN-BARR-VIRUS PROTEIN BCRF1 [J].
HSU, DH ;
MALEFYT, RD ;
FIORENTINO, DF ;
DANG, MN ;
VIEIRA, P ;
DEVRIES, J ;
SPITS, H ;
MOSMANN, TR ;
MOORE, KW .
SCIENCE, 1990, 250 (4982) :830-832
[10]   SERUM LEVELS OF INTERFERON-GAMMA, CYTOTOXIC FACTOR AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHILDHOOD HEMOPHAGOCYTIC SYNDROMES [J].
IMASHUKU, S ;
IKUSHIMA, S ;
ESUMI, N ;
TODO, S ;
SAITO, M .
LEUKEMIA & LYMPHOMA, 1991, 3 (04) :287-292